MolNFT v1 · #147507 · protein
Structure of the microcompartment-associated aminopropanol kinase
6EF6 · Aminoglycoside phosphotransferase: “Structure of the microcompartment-associated aminopropanol kinase”. X-ray diffraction, 3 ligands (BEZ, JFN, NA), 2 pockets (best druggability 0.71). MolNFT v1 #147507 on GenesisL1: 3D structure…
- PDB
- 6EF6
- Type
- protein
- Length
- 325 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Aminoglycoside phosphotransferase
- UniProt
- A0QP47
- Ligands
- BEZ, JFN, NA
- Pockets
- 2 · best druggability 0.71
Structure
x-ray diffraction · 1 distinct chain · 43% helix, 14% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Aminoglycoside phosphotransferase | protein | 325 | 43% helix, 14% strand | A0QP47 |
Ligands and binding sites
- BEZ · Benzoic acid · ligand · chains A
- JFN · (2R)-1-methoxypropan-2-amine · ligand · chains A
- NA · Sodium ion · metal · 2 copies · chains A
- ACT · Acetate ion · additive · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 55 | 0.71 | 0.98 | 16 | BEZ |
| 2 | 86 | 0.46 | 0.81 | 23 | JFN, NA |
Compared structures
- 6EF6 · Structure of the microcompartment-associated aminopropanol kinase · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt A0QP47
- Elsewhere: RCSB PDB 6EF6 · PDBe 6EF6 · UniProt A0QP47
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.